Veracyte Inc. (VCYT)
Veracyte Statistics
Share Statistics
Veracyte has 77.94M shares outstanding. The number of shares has increased by 3.24% in one year.
| Shares Outstanding | 77.94M |
| Shares Change (YoY) | 3.24% |
| Shares Change (QoQ) | 0.9% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 76.84M |
| Failed to Deliver (FTD) Shares | 1.26K |
| FTD / Avg. Volume | 0.14% |
Short Selling Information
The latest short interest is 3.05M, so 3.93% of the outstanding shares have been sold short.
| Short Interest | 3.05M |
| Short % of Shares Out | 3.93% |
| Short % of Float | 3.98% |
| Short Ratio (days to cover) | 4.3 |
Valuation Ratios
The PE ratio is 127.32 and the forward PE ratio is 49.5. Veracyte's PEG ratio is -0.98.
| PE Ratio | 127.32 |
| Forward PE | 49.5 |
| PS Ratio | 6.89 |
| Forward PS | 3.5 |
| PB Ratio | 2.61 |
| P/FCF Ratio | 48.16 |
| PEG Ratio | -0.98 |
Enterprise Valuation
Veracyte Inc. has an Enterprise Value (EV) of 1.79B.
| EV / Earnings | 74.35 |
| EV / Sales | 4.03 |
| EV / EBITDA | 36.47 |
| EV / EBIT | 111.18 |
| EV / FCF | 28.12 |
Financial Position
The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.73 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.04 |
| Total Debt / Capitalization | 4.14 |
| Cash Flow / Debt | 1.48 |
| Interest Coverage | 8071 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is 1.23%.
| Return on Equity (ROE) | 0.02% |
| Return on Assets (ROA) | 0.02% |
| Return on Capital (ROIC) | 1.23% |
| Revenue Per Employee | $540,975.73 |
| Profits Per Employee | $29,293.69 |
| Employee Count | 824 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 6.79 |
Taxes
| Income Tax | 1.61M |
| Effective Tax Rate | 0.06 |
Stock Price Statistics
The stock price has increased by 35.92% in the last 52 weeks. The beta is 1.8, so Veracyte's price volatility has been higher than the market average.
| Beta | 1.8 |
| 52-Week Price Change | 35.92% |
| 50-Day Moving Average | 37.56 |
| 200-Day Moving Average | 33.83 |
| Relative Strength Index (RSI) | 35.29 |
| Average Volume (20 Days) | 914.66K |
Income Statement
In the last 12 months, Veracyte had revenue of 445.76M and earned 24.14M in profits. Earnings per share was 0.31.
| Revenue | 445.76M |
| Gross Profit | 298.14M |
| Operating Income | 16.14M |
| Net Income | 24.14M |
| EBITDA | 49.2M |
| EBIT | 16.14M |
| Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 239.09M in cash and 50.74M in debt, giving a net cash position of 188.35M.
| Cash & Cash Equivalents | 239.09M |
| Total Debt | 50.74M |
| Net Cash | 188.35M |
| Retained Earnings | -443.98M |
| Total Assets | 1.3B |
| Working Capital | 293.63M |
Cash Flow
In the last 12 months, operating cash flow was 75.1M and capital expenditures -11.29M, giving a free cash flow of 63.81M.
| Operating Cash Flow | 75.1M |
| Capital Expenditures | -11.29M |
| Free Cash Flow | 63.81M |
| FCF Per Share | 0.82 |
Margins
Gross margin is 66.88%, with operating and profit margins of 3.62% and 5.41%.
| Gross Margin | 66.88% |
| Operating Margin | 3.62% |
| Pretax Margin | 5.78% |
| Profit Margin | 5.41% |
| EBITDA Margin | 11.04% |
| EBIT Margin | 3.62% |
| FCF Margin | 14.31% |
Dividends & Yields
VCYT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.03% |
| FCF Yield | 2.72% |
Analyst Forecast
The average price target for VCYT is $45, which is 49.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $45 |
| Price Target Difference | 49.4% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 12.38 |
| Piotroski F-Score | 7 |